O-12: BUILDING LOCAL CAPACITY FOR HYDROXYUREA PHARMACOKINETICS AND PRECISION DOSING IN LOW-RESOURCE SETTINGS

por L., SMART, M., CHARLES, A., POWER-HAYS, T., HOWARD, K., MCELHINNEY, E., AMBROSE, R., WARE
Publicado 2022

P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE

por L., SMART, C., SEGBEFIA, T., LATHAM, S., STUBER, K., AMISSAH-ARTHUR, A., LANE, Y., DEI-ADOMAKOH, R., WARE
Publicado 2022

O-01: HYDROXYUREA REDUCES THE TRANSFUSION BURDEN IN CHILDREN WITH SICKLE CELL ANEMIA IN SUB-SAHARAN AFRICA: THE REACH EXPERIENCE

por A., POWER-HAYS, G., TOMLINSON, L., TSHILOLO, B., SANTOS, T., WILLIAMS, P., OLUPOT-OLUPOT, L., SMART, P., MCGANN, S., STUBER, T., LATHAM, R., WARE
Publicado 2022